Literature DB >> 15842329

Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.

Donna M MacCallum1, Frank C Odds.   

Abstract

We characterized the intravenous (i.v.) challenge model for disseminated Candida albicans infection in female BALB/c and DBA/2 mice. Clearance of fungi from the bloodstream and appearance of fungi in tissues were measured at intervals after challenge with various doses of C. albicans. The wild-type isolate SC5314 and derived strains CAF2-1 and CAI-4 transformed with CIp10 were of equal virulence in the model. Variability in mouse survival times, kidney fungal burdens and cachexia was lowest when challenge inocula were within the range 10(4)-10(5) CFU g(-1) body weight in BALB/c mice, but brain fungal burdens and outcomes in DBA/2 mice were variable for all inocula tested. Critical times in the development of infections in optimally challenged BALB/c mice were at 5-10 h (bloodstream fully cleared of fungi), 24 h (start of exponential fungal growth in kidneys) and 48 h (50% of blood cultures become positive). Differential involvement of right and left kidneys occurred almost exclusively in mice challenged with <2 x 10(4) CFU g(-1). We conclude that the i.v. challenge model in female BALB/c mice is now sufficiently well characterized to permit more refined experimentation in future virulence studies with C. albicans mutants.

Entities:  

Mesh:

Year:  2005        PMID: 15842329     DOI: 10.1111/j.1439-0507.2005.01121.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  83 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

2.  Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.

Authors:  Taiga Miyazaki; Yoshitsugu Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Shunichi Miyakoshi; John E Bennett; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 3.  Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis.

Authors:  Sarah E W Grubb; Craig Murdoch; Peter E Sudbery; Stephen P Saville; Jose L Lopez-Ribot; Martin H Thornhill
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

4.  A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections.

Authors:  Brice Enjalbert; Anna Rachini; Govindsamy Vediyappan; Donatella Pietrella; Roberta Spaccapelo; Anna Vecchiarelli; Alistair J P Brown; Christophe d'Enfert
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

Review 5.  Candida and invasive candidiasis: back to basics.

Authors:  C S-Y Lim; R Rosli; H F Seow; P P Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

6.  Yeast and Filaments Have Specialized, Independent Activities in a Zebrafish Model of Candida albicans Infection.

Authors:  Brittany G Seman; Jessica L Moore; Allison K Scherer; Bailey A Blair; Sony Manandhar; Joshua M Jones; Robert T Wheeler
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

7.  Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.

Authors:  Donna M MacCallum; Alix Coste; Françoise Ischer; Mette D Jacobsen; Frank C Odds; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

8.  Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections.

Authors:  Samir Jawhara; Elzbieta Pluskota; Dmitriy Verbovetskiy; Olena Skomorovska-Prokvolit; Edward F Plow; Dmitry A Soloviev
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.

Authors:  Casey T Nishiya; Gayle M Boxx; Kerry Robison; Carol Itatani; Thomas R Kozel; Mason X Zhang
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

10.  Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney.

Authors:  Louise A Walker; Donna M Maccallum; Gwyneth Bertram; Neil A R Gow; Frank C Odds; Alistair J P Brown
Journal:  Fungal Genet Biol       Date:  2008-11-06       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.